Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience
- PMID: 19470056
- DOI: 10.1111/j.1468-3083.2009.03093.x
Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience
Similar articles
-
Etanercept in psoriasis treatment.Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):222-6. Ann Univ Mariae Curie Sklodowska Med. 2003. PMID: 15314989 Review.
-
Etanercept for the treatment of psoriasis.Skin Therapy Lett. 2006 Feb;11(1):1-4. Skin Therapy Lett. 2006. PMID: 16485060 Review.
-
[Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].Ann Dermatol Venereol. 2010 Apr;137(4 Suppl):13-5. doi: 10.1016/S0151-9638(10)70012-0. Ann Dermatol Venereol. 2010. PMID: 20510165 Clinical Trial. French. No abstract available.
-
Adolescent plaque psoriasis: our experience using etanercept.J Eur Acad Dermatol Venereol. 2009 Aug;23(8):976-7. doi: 10.1111/j.1468-3083.2008.03081.x. Epub 2009 Jan 13. J Eur Acad Dermatol Venereol. 2009. PMID: 19207668 No abstract available.
-
Etanercept for psoriasis in the pediatric population: experience in nine patients.Pediatr Dermatol. 2006 Jan-Feb;23(1):67-71. doi: 10.1111/j.1525-1470.2006.00174.x. Pediatr Dermatol. 2006. PMID: 16445417
Cited by
-
Heterogeneity of response to biologic treatment: perspective for psoriasis.J Invest Dermatol. 2014 Jan;134(1):18-23. doi: 10.1038/jid.2013.326. Epub 2013 Aug 6. J Invest Dermatol. 2014. PMID: 23921949
-
Diet and psoriasis, part I: Impact of weight loss interventions.J Am Acad Dermatol. 2014 Jul;71(1):133-40. doi: 10.1016/j.jaad.2014.02.012. Epub 2014 Apr 4. J Am Acad Dermatol. 2014. PMID: 24709272 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical